Genetic Risk
A family history of schizophrenia or related psychotic disorders raises risk, with heritability estimated near 80 percent across studies.

Compassionate, Stigma-Free Care for People Living With Schizophrenia
Recognizing the Signs
Schizophrenia, classified in the DSM-5-TR under schizophrenia spectrum and other psychotic disorders, is a chronic brain illness that affects how a person thinks, feels and perceives reality. According to the National Institute of Mental Health, schizophrenia affects approximately 0.7 to 1 percent of people during their lifetime, and symptoms typically emerge in the late teens through the early or mid-30s.
If you or someone you love is living with schizophrenia, you may notice positive symptoms such as hallucinations or delusions, negative symptoms such as flat affect, low motivation or social withdrawal, and cognitive symptoms such as trouble focusing or remembering. These experiences can feel frightening and isolating, especially during a first episode or when the diagnosis is new.
Schizophrenia is a medical condition, not a character flaw or a personal failing. With sustained antipsychotic medication, supportive psychotherapy and family education, many people stabilize, return to work or school and build full, meaningful lives. Early, consistent treatment makes a measurable difference in long-term outcomes.
Understanding the Root Causes
Schizophrenia is understood as a disorder of brain circuits. Research summarized by Marder and Cannon (NEJM, 2019) points to dopamine dysregulation in the mesolimbic pathway, which is linked to positive symptoms such as hallucinations and delusions, alongside reduced dopamine activity in mesocortical pathways that contributes to negative and cognitive symptoms. Disruptions in glutamate signaling at NMDA receptors and abnormalities in prefrontal and hippocampal function also play a role.
Genetics carry significant weight. Heritability estimates approach 80 percent, although no single gene causes the illness. Many small genetic variations interact with environmental factors such as prenatal infection, obstetric complications, early cannabis use during brain development and significant psychosocial stress. Information from the American Psychiatric Association further explains how this gene by environment interaction shapes risk.
This is why a careful psychiatric evaluation matters. Our practice takes the time to map your symptom pattern, medical history and family history so that medication management can target the underlying biology, not just the surface symptoms.
How Schizophrenia Presents From Adolescence Through Adulthood
Schizophrenia often begins quietly. Many people experience a prodromal phase months or even years before the first full psychotic episode, marked by social withdrawal, declining school or work performance, unusual beliefs, sleep disturbance or subtle changes in speech. In late adolescence and the early 20s, these signs can be mistaken for typical developmental stress, which is why a thoughtful clinical assessment is so important.
Dr. Maria Carmen V. Gonzales-Vigilar is board certified in general, child and adolescent, and adult psychiatry, which means she can evaluate early warning signs in teens and young adults and continue care as a patient moves into adulthood. Dr. Ayman Abdel Bakey brings more than 30 years of adult and geriatric psychiatric experience, which is essential for patients managing schizophrenia later in life, when medical comorbidities and medication interactions become more complex.
Across every life stage, our care focuses on stability, function and dignity. Pharmacogenomic insight through Genomind gene testing can guide antipsychotic selection by identifying CYP450 metabolizer status, helping us reduce trial and error and choose medications more likely to be tolerated.
Expert Care in Ashburn
Finding Your Best Approach
| Treatment | Best For | Session Time | Results Timeline | Maintenance |
|---|---|---|---|---|
| Psychiatric Evaluation | Diagnosis + risk assessment | 60-90 min | Same visit insights | As recommended |
| Medication Management | Symptom stabilization | 30 min follow-ups | 2-6 weeks | Ongoing visits |
| Genomind Gene Testing | Antipsychotic selection | Cheek swab in office | 2-4 weeks for results | One-time test |
Recognizing When to Seek Help
About Schizophrenia
Early signs often include social withdrawal, declining school or work performance, sleep changes, unusual beliefs and subtle disorganization of thought. These can appear months before a first psychotic episode and deserve a careful psychiatric evaluation.
Diagnosis is clinical. Your psychiatrist conducts a detailed interview, reviews symptom timeline and rules out medical causes, substance effects and mood disorders such as bipolar disorder. Collateral information from family is often helpful, with your consent.
Sustained antipsychotic medication is the foundation, supported by psychotherapy, family education and social skills support. A 2013 Lancet network meta-analysis by Leucht and colleagues found meaningful differences in efficacy and tolerability across 15 antipsychotics, which is why individualized selection matters.
Yes. Genomind looks at CYP450 metabolizer status and other relevant variants, helping your psychiatrist anticipate how you may process specific antipsychotics, antidepressants or mood stabilizers and reduce trial and error during titration.
Many patients notice early improvement in sleep, agitation and intensity of positive symptoms within 1 to 2 weeks, with broader stabilization typically over 2 to 6 weeks. Negative and cognitive symptoms often improve more gradually over months.
Co-occurring depression and anxiety are common in people living with schizophrenia, and they require their own attention within the treatment plan. Learn more about how we approach depression and anxiety alongside psychotic disorders.
For many people with schizophrenia, long-term maintenance medication is the safest path because stopping antipsychotics abruptly is a leading cause of relapse. Some patients eventually reduce doses under close psychiatric supervision, while others remain stable on a steady regimen for years.